April 4, 2025
Published by Meranda Parascandola at April 4, 2025

FDA INTERACT Meetings: What You Need to Know

For early-stage drug developers, engaging with the FDA at the right time can be critical to success. One such opportunity is the INitial Targeted Engagement for Regulatory Advice on CBER/CDER ProducTs (INTERACT) meeting. This meeting provides early-stage guidance from the FDA’s Center for Biologics Evaluation and Research (CBER) and Center […]
Do you like it?
Read more
1...4041424344...158

WHAT CAN DSI DO FOR YOU?



REGULATORY
AFFAIRS



CHEMISTRY
MANUFACTURING
CONTROLS



QUALITY
ASSURANCE